The newest AI-based imaging processing software from Subtle Medical has received FDA clearance.
The solution, SubtleMR, uses deep learning algorithms to improve the quality of MR images. It is compatible with existing MRI scanners and PACS solutions from a variety of vendors. Subtle Medical’s SubtlePET solution gained FDA approval in 2018.
“We are pleased to receive FDA clearance for SubtleMR, and we look forward to helping radiology departments and imaging centers get the most out of their existing MRI scanners," Enhao Gong, PhD, founder and CEO of Subtle Medical, said in a prepared statement. “This is an important milestone for the company as it broadens our portfolio of technologies developed for radiologists and their patients.”
“One of the most exciting things about deep learning reconstruction is how it redefines the usual negotiation between exam time and image quality,” Christopher Hess, MD, chair of the department of radiology and biomedical imaging at the University of California San Francisco, said in the same statement. “This could lead to significant downstream value for imaging operations and for patient experience.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.